COVID-19: Brazil clears emergency use of Sinovac; AstraZeneca vaccines; shots begin

Minutes after Anvisa’s board voted unanimously to approve both vaccines, Monica Calazans, a 54-year-old  nurse in Sao Paulo, became the first person to be inoculated in Brazil, receiving the Chinese vaccine known as CoronaVac.           

President Jair Bolsonaro, a coronavirus skeptic who has refused to take a vaccine himself, is under growing pressure to start inoculations in Brazil, which has lost more than 200,000 to COVID-19 – the worst death toll outside the United States. (Graphic: https://tmsnrt.rs/34pvUyi)

However, delays with vaccine shipments and testing results have held up vaccinations in the country, once a global leader in mass immunizations and now a regional laggard after peers such as Chile and Mexico started giving shots last month.

Bolsonaro’s government was planning to kick off a national immunization program this week but is still waiting on shipments of the AstraZeneca vaccine at the center of its plans. That has added to public frustration and offered a political rival the chance to upstage the right-wing president.

Sao Paulo Governor Joao Doria, who oversees the Butantan biomedical center that partnered with Sinovac in Brazil, said widespread vaccinations could start immediately.

“I have determined that as soon as Anvisa approves the emergency use of the Butantan vaccine, the Butantan Institute will immediately deliver the vaccines to the Health Ministry to be distributed to SP (Sao Paulo), DF (Federal District) and all Brazilian states,” Doria tweeted just before the deciding vote was cast by Anvisa’s board.

Health Minister Eduardo Pazuello told a news conference that the rush to start vaccinating immediately was an illegal “marketing ploy,” and the government would start distributing the vaccines to states on Monday morning. Brazil could eventually vaccinate 1 million people per day, he said.

Bolsonaro, for whom Doria is a potential center-right rival to his 2022 re-election efforts, has taunted the governor over CoronaVac’s disappointing 50% efficacy in Brazilian trials, but the federal Health Ministry has agreed to acquire and distribute the shot for the national immunization drive.

Adding to urgency for vaccinations, a second wave of the outbreak in Brazil is snowballing as the country confronts a new, potentially more contagious variant of the coronavirus that originated in Amazonas and prompted Britain and Italy to bar entry to Brazilians.

Butantan, which is set up to fill and finish CoronaVac doses on its production line, plans to supply 46 million doses of the two-dose shot by April, the institute said in a statement.

The federally funded Fiocruz institute is still waiting for a delayed shipment of the active ingredient in the AstraZeneca vaccine for finishing on a Rio de Janeiro assembly line.

The Health Ministry has scrambled to line up 2 million ready doses of the AstraZeneca vaccine from India, but officials there have suggested it may take weeks to approve exports. Pazuello said on Sunday he expected the doses from India this week.

Post a comment or leave a trackback: Trackback URL.

Comments

  • kamtanblog  On 01/19/2021 at 4:07 am

    Simple Simon asks

    Who pays for this @$19.50 a dose ?
    Which drug cartel will profit most from its roll out ?
    How many lives will be lost/saved from this
    mass immunisation ?

    More questions than answers

    Now it’s a political game/role playing by the political jackasses in power ?

    My jury out !

    Kamtan uk-ex-EU

  • brandli62  On 01/19/2021 at 7:33 am

    J&J had announced that they will provide their vaccine at production costs and they will not make profits. Their vector-based SARS-CoV2 vaccine needs to be be taken once and can be stored in fridges. It’s costs are 5-10 fold lower than those for the mRNA-based vaccines of Moderna and Pfizer/BioNTech. Phase 3 results should be made public by the end of January.

  • the only  On 01/20/2021 at 1:25 pm

    I hope the health people here in Guyana knows about this J&J vaccine.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s